DelMar Pharmaceuticals Inc $1.44
|Trade Time:||Mar 10 08:10 PM Eastern Daylight Time|
|Change:||0.00 (0.00 %)|
Quotes displayed are delayed by 15 minutes. Market data is provided by Xignite
Get DMPI Trend Analysis - it has underperformed the S&P 500 by 62%
|No ETF alternatives available.|
|Date||Name||Title||Volume||Trade Price||Holding Change|
|3/04/2014||Brown Dennis M||Chief Scientific Officer||5,000||$1.56||0.17%|
|2/21/2014||BACHA JEFFREY||CEO and PRESIDENT||5,000||$1.00||18.52%|
|2/13/2014||BACHA JEFFREY||CEO and PRESIDENT||5,000||$0.80||22.73%|
|2/11/2014||Bell John K||Director||9,000||$0.83||90.00%|
|2/05/2014||TOTH ROBERT JOSEPH JR||Director||9,000||$0.88||94.74%|
DMPI Stock Analysis
- No results found.
Get the four benefits of managed futures as outlined in this booklet.
Learn from Warren Buffett, George Soros and More!
Discover Investing Strategies that will Benefit Every Investor Today!